to the Seroxat User Group Website
The Seroxat User Group was set up by UK
patients using the GlaxoSmithKline medication, Seroxat, to provide support
and advice to users of the medication, and to their families and friends.
We are a self-funding, non profit
This web site contains information about
the aims of the group, as well as research and articles on the effects
ACTION September 2015
those who have an interest in the Seroxat Group Action, the
case remains stayed in the High Court while Solicitors acting
for the Claimants put alternative funding into place for the
case to continue to Trial.
Some Clients appear to have received letters from their previous
solicitors, Hugh James, inviting them to discontinue their Claims
and enclosing a form to sign. If you receive such a letter advising
you to discontinue, please do not complete this Form, but instead,
If you have managed to withdraw from
an SSRI and are still experiencing some side-effects or withdrawal
symptoms, we'd like to hear from you.
What is Seroxat?
Seroxat is a second generation SSRI
(Selective Serotonin Re-Uptake Inhibitor). SSRI's work by inhibiting serotonin
re-uptake transporters thereby increasing serotonin levels in the brain.
Serotonin is a chemical which affects the mood. By boosting that chemical
the patient should feel better.
Manufactured by GlaxoSmithKline, Seroxat was first licensed
in the UK on 11th December 1990 and was re-licensed
on the 9th January 1998.
Seroxat's original licence was to treat episodes of
mild to moderate depression. It is now licensed for the short term treatment
of symptoms of depressive illness.
The Medicines and Healthcare Products Regulatory Agency (MHA) have
compiled a Questions
and Answers Document on Seroxat.